Metastatic Breast Cancer Research Investment

Learn more about Komen’s investment in metastatic breast cancer research.  Since our inception, we’ve invested more than $133 million in over 350 research grants and 35 clinical trials focused on metastatic breast cancer.

Metastisis Investment